Loading ETF profile…

يهدف صندوق First Trust NYSE Arca Biotechnology Index Fund (FBT) المتداول في البورصة (ETF) إلى عكس تحركات الأسعار والدخل الناتج عن مؤشر NYSE Arca Biotechnology Index بدقة. يتمثل هدفه الأساسي في مطابقة أداء هذا المؤشر المرجعي عن كثب، قبل احتساب رسوم ونفقات تشغيل الصندوق.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc. | 5.54% | $154.87M |
| VCYT | Veracyte, Inc. | 4.99% | $139.70M |
| NEO | NeoGenomics, Inc. | 4.96% | $138.65M |
| ILMN | Illumina, Inc. | 4.24% | $118.75M |
| BRKR | Bruker Corporation | 4.24% | $118.54M |
| ALKS | Alkermes Plc | 4.20% | $117.49M |
| NTRA | Natera, Inc. | 3.82% | $106.82M |
| KRYS | Krystal Biotech, Inc. | 3.79% | $106.03M |
| NBIX | Neurocrine Biosciences, Inc. | 3.65% | $102.07M |
| TECH | Bio-Techne Corporation | 3.47% | $97.09M |
| AXSM | Axsome Therapeutics, Inc. | 3.46% | $96.85M |
| EXEL | Exelixis, Inc. | 3.42% | $95.65M |
| BIIB | Biogen Inc. | 3.26% | $91.31M |
| RGEN | Repligen Corporation | 3.26% | $91.15M |
| INCY | Incyte Corporation | 3.21% | $89.85M |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 3.07% | $85.97M |
| HALO | Halozyme Therapeutics, Inc. | 3.03% | $84.80M |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.97% | $83.18M |
| ARGX | argenx SE (ADR) | 2.96% | $82.80M |
| BMRN | BioMarin Pharmaceutical Inc. | 2.93% | $82.03M |
| AMGN | Amgen Inc. | 2.77% | $77.60M |
| GMAB | Genmab A/S (ADR) | 2.75% | $77.03M |
| ONC | BeOne Medicines Ltd. (ADR) | 2.65% | $74.17M |
| GILD | Gilead Sciences, Inc. | 2.55% | $71.42M |
| BNTX | BioNTech SE (ADR) | 2.55% | $71.27M |